Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 2, 2009, Pages 328-331

  Winther, Thilde N ^a   Kristensen, Tim D ^a   Kaltoft, Margit S ^b   Konradsen, Helle B ^b   Knudsen, Jenny D ^a   Høgh, Birthe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Children; Invasive pneumococcal disease; Sequelae; Streptococcus pneumoniae; Vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CONTROLLED STUDY; DENMARK; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS PNEUMONIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES;

EID: 58449095651     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.01080.x     Document Type: Article

References (28)

1. Howitz M, Valentiner-Branth P, Lambertsen L, Christensen JJ. Purulent meningitis 2006. EPI-NEWS 2007 45. Available at : http://www.ssi.dk/sw52443.asp (accessed November 6, 2007).
2. Kyaw MH, Christie P, Jones IG, Campbell H. The changing epidemiology of bacterial meningitis and invasive non-meningitis bacterial disease in Scotland during the period 1983-99. Scand J Infect Dis 2003 34 : 289 98.
3. WHO position paper. Pneumococcal vaccines. Wkly Epidemiol Rec 2007 82 : 93 104.
4. Jefferson T, Ferroni E, Curtale F, Rossi PG, Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 2006 6 : 405 10.
5. ACIP. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Reports. Recommended Rep 2000 49 (RR-9 1 35.
6. American Academy of Pediatrics. Committee on Infectious Disease. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevenar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000 106 : 362 66.
7. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. Morb Mortal Wkly Rep 2005 54 : 893 97.
8. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccine. Vaccine 2003 16 : 1815 25.
9. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006 295 : 1668 74.
10. Andersen PH, Hogh B. Pneumococcal vaccination of at-risk children. EPI-NEWS 2007 11. Available at : http://www.ssi.dk/sw48375.asp (accessed March 14, 2007).
11. Valentiner-Branth P, Andersen PH, Christiansen AH, Vestergaard L, Glismann S, Christensen JJ et al. Pneumococcal disease in the childhood vaccination programme. EPI-NEWS 2007 37a+b. Available at : http://www.ssi.dk/ sw51372.asp (accessed September 12, 2007).
12. Sorensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993 31 : 2097 2100.
13. The Swedish Reference Group for Antibiotics. The Swedish Association of Medicine, the Swedish Institute for Infectious Disease Control and the Swedish strategic programme against antibiotic resistance. Available at : http://www.srga.org/.
14. Kaltoft MS, Zeuthen N, Konradsen HB. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr Suppl 2000 435 : 1 8.
15. Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 2002 9 : 358 65.
16. Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E et al. On behalf of the Oxford Invasive Pneumococcal Surveillance Group. Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England. J Med Microbiol 2008 57 (Pt 4 480 87.
17. Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis 2001 33 : 667 72.
18. Winters M, Patrick DM, Marra F, Buxton J, Chong M, Isaac-Renton JL et al. Epidemiology of invasive pneumococcal disease in BC during the introduction of conjugated pneumococcal vaccine. Can J Public Health 2008 99 : 57 61.
19. Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008 46 : 1664 72.
20. Arditi M, Mason EO, Bradley JS, Tan TQ, Barson WJ, Schutze GE et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998 102 : 1087 97.
21. Pedersen FK, Henrichsen J. Pneumococcal meningitis and bacteraemia in Danish children 1969-1978. Serotypes, incidence and outcome. Acta Pathol Microbiol Immunol Scand [B] 1983 91 : 129 34.
22. Kayhty H, Eskola J. New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis 1996 2 : 289 98.
23. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 2007 26 : 473 4.
24. Gonzales BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO. Streptococcus pneumoniae serogroups 15 and 33. An increasing cause of pneumococcal infections in children in United States after the introduction of pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006 25 : 301 05.
25. O'Brien KL, Weatherholtz R, Millar EV. Replacement invasive pneumococcal disease 9 years after introduction of PCV among a population at high risk of IPD: The Navajo Experience. In : Program and Abstracts of the 5th International Symposium on Pneumococci and Pneumococcal Diseases April 2-6, 2006; Alice Springs, Australia, Abstract P04. 17 : 189.
26. Antonio M, Dada-Adegbola H, Biney E, Awine T, O'Callaghan J, Pfluger V, et al. Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis 2008 8 : 81.
27. DANMAP. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, and humans in Denmark. ISSN 1600-3032, 2006. Available at : http://www.danmap.org/.
28. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000 19 : 187 95.